tiprankstipranks
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market
LOVFF
Cannara Biotech
RESEARCH TOOLSreports

Cannara Biotech (LOVFF) Ratios

12 Followers

Cannara Biotech Ratios

LOVFF's free cash flow for Q3 2026 was C$0.22. For the 2026 fiscal year, LOVFF's free cash flow was decreased by C$ and operating cash flow was C$0.10. See a summary of the company’s cash flow.
Ratios
TTM
Aug 25Aug 24Nov 23Aug 22
Liquidity Ratios
Current Ratio
 3.00 2.40 2.50 2.44 3.46
Quick Ratio
 1.29 1.10 1.01 0.85 1.86
Cash Ratio
 0.67 0.42 0.25 0.20 1.02
Solvency Ratio
 0.24 0.29 0.19 0.19 0.11
Operating Cash Flow Ratio
 0.57 0.59 0.40 0.26 -0.51
Short-Term Operating Cash Flow Coverage
 1.89 1.54 1.16 0.91 -3.09
Net Current Asset Value
C$ 29.05MC$ 15.73MC$ 705.36KC$ -10.08MC$ -17.89M
Leverage Ratios
Debt-to-Assets Ratio
 0.19 0.25 0.31 0.32 0.39
Debt-to-Equity Ratio
 0.29 0.41 0.55 0.57 0.73
Debt-to-Capital Ratio
 0.23 0.29 0.35 0.36 0.42
Long-Term Debt-to-Capital Ratio
 0.18 0.22 0.30 0.33 0.41
Financial Leverage Ratio
 1.55 1.65 1.76 1.77 1.88
Debt Service Coverage Ratio
 0.69 1.33 1.15 1.40 1.91
Interest Coverage Ratio
 0.04 5.10 1.78 2.24 1.11
Debt to Market Cap
 0.19 0.25 0.78 0.51 0.41
Interest Debt Per Share
 0.40 0.50 0.60 0.57 0.59
Net Debt to EBITDA
 1.08 0.97 2.75 2.63 3.80
Profitability Margins
Gross Profit Margin
26.30%44.00%36.44%47.56%48.36%
EBIT Margin
7.33%20.29%10.78%18.91%12.49%
EBITDA Margin
11.89%26.26%18.55%27.54%26.62%
Operating Profit Margin
0.10%20.68%12.33%20.76%10.25%
Pretax Profit Margin
13.82%16.86%5.49%12.13%6.43%
Net Profit Margin
9.22%12.18%7.88%12.13%6.43%
Continuous Operations Profit Margin
9.22%12.18%7.88%12.13%6.43%
Net Income Per EBT
66.72%72.26%143.59%100.00%100.00%
EBT Per EBIT
13676.61%81.53%44.49%58.42%62.78%
Return on Assets (ROA)
5.58%7.75%4.16%4.91%1.84%
Return on Equity (ROE)
9.45%12.79%7.32%8.71%3.45%
Return on Capital Employed (ROCE)
0.07%16.51%7.89%9.88%3.23%
Return on Invested Capital (ROIC)
0.05%10.86%7.34%9.41%3.17%
Return on Tangible Assets
5.66%7.75%4.16%4.91%1.84%
Earnings Yield
5.52%7.86%10.51%7.78%1.95%
Efficiency Ratios
Receivables Turnover
 6.36 7.61 6.27 5.41 4.16
Payables Turnover
 8.16 5.42 26.45 3.38 2.17
Inventory Turnover
 1.56 1.35 1.30 0.89 0.98
Fixed Asset Turnover
 1.25 1.25 0.96 0.64 0.43
Asset Turnover
 0.61 0.64 0.53 0.40 0.29
Working Capital Turnover Ratio
 1.86 2.43 2.30 1.92 1.73
Cash Conversion Cycle
 246.68 251.03 325.90 370.01 293.73
Days of Sales Outstanding
 57.40 47.98 58.21 67.52 87.76
Days of Inventory Outstanding
 233.99 270.36 281.49 410.49 374.25
Days of Payables Outstanding
 44.72 67.31 13.80 108.00 168.28
Operating Cycle
 291.39 318.33 339.70 478.01 462.01
Cash Flow Ratios
Operating Cash Flow Per Share
 0.19 0.22 0.12 0.06 -0.07
Free Cash Flow Per Share
 0.05 0.15 0.04 -0.05 -0.25
CapEx Per Share
 0.14 0.07 0.08 0.11 0.18
Free Cash Flow to Operating Cash Flow
 0.26 0.68 0.30 -0.82 3.54
Dividend Paid and CapEx Coverage Ratio
 1.35 3.15 1.43 0.55 -0.39
Capital Expenditure Coverage Ratio
 1.35 3.15 1.43 0.55 -0.39
Operating Cash Flow Coverage Ratio
 0.50 0.48 0.22 0.12 -0.13
Operating Cash Flow to Sales Ratio
 0.16 0.19 0.13 0.09 -0.17
Free Cash Flow Yield
2.41%8.21%5.25%-4.97%-18.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.52 12.86 9.51 12.86 51.34
Price-to-Sales (P/S) Ratio
 1.67 1.55 0.75 1.56 3.30
Price-to-Book (P/B) Ratio
 1.56 1.63 0.70 1.12 1.77
Price-to-Free Cash Flow (P/FCF) Ratio
 41.50 12.18 19.06 -20.10 -5.49
Price-to-Operating Cash Flow Ratio
 10.65 8.31 5.73 16.42 -19.47
Price-to-Earnings Growth (PEG) Ratio
 -0.50 0.13 -1.17 0.07 -0.31
Price-to-Fair Value
 1.56 1.63 0.70 1.12 1.77
Enterprise Value Multiple
 15.12 6.87 6.79 8.29 16.21
Enterprise Value
 211.77M 193.48M 102.95M 130.81M 154.63M
EV to EBITDA
 15.12 6.87 6.79 8.29 16.21
EV to Sales
 1.80 1.80 1.26 2.28 4.31
EV to Free Cash Flow
 44.71 14.17 32.03 -29.45 -7.18
EV to Operating Cash Flow
 11.47 9.67 9.64 24.06 -25.44
Tangible Book Value Per Share
 1.25 1.11 0.98 0.89 0.76
Shareholders’ Equity Per Share
 1.27 1.11 0.98 0.89 0.76
Tax and Other Ratios
Effective Tax Rate
 0.33 0.28 -0.44 0.00 -0.24
Revenue Per Share
 1.19 1.16 0.91 0.64 0.41
Net Income Per Share
 0.11 0.14 0.07 0.08 0.03
Tax Burden
 0.67 0.72 1.44 1.00 1.00
Interest Burden
 1.89 0.83 0.51 0.64 0.51
Research & Development to Revenue
 0.01 <0.01 0.01 0.02 0.04
SG&A to Revenue
 0.24 0.22 0.16 0.19 0.24
Stock-Based Compensation to Revenue
 <0.01 0.01 0.02 0.03 <0.01
Income Quality
 1.70 1.53 1.66 0.78 -2.64
Currency in CAD